PPMD Applauds FDA for Landmark Approval of First-Ever Gene Therapy Treatment for Duchenne for Patients Ages 4-5 Years Old

Organization Will Continue to Support Patient Access and Drive Policies and Projects That Support Development and Approval of More Therapies WASHINGTON, June 22, 2023 /PRNewswire/ — Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne…